The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE‐DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)

BACKGROUND: The RE‐DUAL PCI trial demonstrated that in patients with nonvalvular atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), dual therapy with dabigatran and a P2Y(12) inhibitor, either clopidogrel or ticagrelor, reduced the risk of bleeding without an increased ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Eccleston, David S., Kim, Joseph M., ten Berg, Jurien M., Steg, P. Gabriel, Bhatt, Deepak L., Hohnloser, Stefan H., de Veer, Anne, Nordaby, Matias, Miede, Corinna, Kimura, Takeshi, Lip, Gregory Y. H., Oldgren, Jonas, Cannon, Christopher P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259156/
https://www.ncbi.nlm.nih.gov/pubmed/34042199
http://dx.doi.org/10.1002/clc.23649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259156/
https://www.ncbi.nlm.nih.gov/pubmed/34042199
http://dx.doi.org/10.1002/clc.23649

Ejemplares similares